Vasodilatateurs périphériques
Revu par Dr Philippa Vincent, MRCGPDernière mise à jour par Dr Surangi Mendis, MRCGPLast updated 28 sept. 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Add to preferred sources on Google
Les vasodilatateurs périphériques sont des médicaments utilisés pour traiter les affections qui affectent les vaisseaux sanguins dans les parties extérieures (périphériques) du corps, comme les bras et les jambes. Par exemple, ils sont utilisés pour traiter la maladie artérielle périphérique et le phénomène de Raynaud. Ils soulagent les symptômes de ces affections en dilatant les vaisseaux sanguins, empêchant ainsi leur rétrécissement (constriction). Ces médicaments ne sont généralement prescrits qu'après avoir essayé des mesures d'auto-assistance et si les symptômes ne s'améliorent pas.
At a glance
Peripheral vasodilators are medicines that widen blood vessels in the limbs.
They are used to treat peripheral arterial disease and Raynaud's phenomenon.
Different types of these medicines are available to prescribe, such as nifedipine and naftidrofuryl.
They are usually prescribed if other self-help measures have not improved symptoms.
Possible side-effects include headache, flushing, or stomach problems.
You need a prescription from a doctor to get these medicines.

Vous n'êtes pas sûr de mélanger des médicaments ?
Vérifiez les interactions possibles entre les médicaments, les compléments et les aliments avant de les prendre ensemble.
Dans cet article:
Video picks for Médicaments pour le cœur et le sang
Continuez à lire ci-dessous
What are peripheral vasodilators?
Peripheral vasodilators are used in peripheral arterial disease (PAD) and intermittent claudication to try to open up (dilate) the arteries; this helps to increase the distance you can walk before pain develops.
In Phénomène de Raynaud they are used to dilate the small blood vessels and prevent them from constricting. This helps to maintain the blood supply to the fingers, etc.
The peripheral vasodilator medications all reduce 'vascular resistance'. This is the resistance that should be overcome to push blood through the vessels in the limbs, to allow blood to flow.
There are a number of different peripheral vasodilator drugs. They include, nifedipine, cilostazol, moxisylyte, naftidrofuryl and pentoxifylline. These medicines are available as tablets and capsules and each one may have various other brand names (see Generic Medicines vs Brand Names).
Inositol nicotinate and pentoxifylline are not considered effective for PAD. Pentoxifylline and moxisylyte are not considered effective for Raynaud's phenomenon.
When are peripheral vasodilators usually prescribed?
Retour au sommaireIn cases of intermittent claudication, a vasodilator is usually only prescribed if self-help measures such as exercise have not improved the symptoms and surgery is not being considered.
However, they do not work in all cases. Therefore, there is no point in continuing with these medicines if an improvement in symptoms is not seen within a few weeks. If symptoms do not improve, stopping treatment would usually be advised. If symptoms improve, the treatment can be continued. The treatment is usually reviewed regularly to ensure that it is still being of benefit.
In Raynaud's phenomenon, nifedipine is usually only prescribed after self-help measures (such as keeping the whole body warm, including the hands and feet, and stopping smoking) have been tried and the symptoms have not improved. Usually a short course of nifedipine is prescribed to begin with to see if it works..
Continuez à lire ci-dessous
How do peripheral vasodilators work?
Retour au sommairePeripheral vasodilators work in slightly different ways to one another.
Cilostazol and inositol nicotinate work by widening the arteries that supply blood to the legs. Cilostazol also improves circulation by keeping platelets in the blood from sticking together and clotting.
Naftidrofuryl works by blocking the effects of a chemical called serotonin on the blood vessels. As a serotonin receptor blocker, Naftidrofuryl widens blood vessels to improve blood flow and also by allowing the body to make better use of oxygen available in the blood.
Nifédipine is a type of medicine called a calcium-channel blocker. It is sometimes used to treat high blood pressure but it is also a peripheral vasodilator. It works by widening the blood vessels and stopping them from going into a spasm or narrowing.
Moxisylyte is a type of medicine called an alpha-blocker. It works by relaxing the blood vessels, which in turn maintains the supply of blood to the fingers, toes, ears or nose.
Pentoxifylline works by decreasing the thickness of the blood. Blood is then able to flow more easily, especially in the small blood vessels of the hands and feet.
Which peripheral vasodilator is usually prescribed?
Retour au sommairePeripheral arterial disease (PAD):
national guidelines only recommend the use of naftidrofuryl for people with intermittent claudication caused by PAD. Other peripheral vasodilators are not normally prescribed because there is little evidence that any of the others work very well for this condition. However, cilostazol can sometimes be used for the treatment of PAD in selected patients who do not respond to other treatments.
Raynaud's phenomenon:
Nifedipine is recommended to reduce the number and severity of 'vasospastic' attacks - when the blood vessels become narrow (constrict). Other peripheral vasodilators are not normally prescribed, as there is not much evidence to show that they work very well for Raynaud's phenomenon.
Sometimes, if the side-effects of nifedipine cannot be tolerated, a doctor may consider prescribing a different calcium-channel blocker such as nicardipine, amlodipine ou félodipine. These medicines are not licensed to treat Raynaud's disease. Rarely, naftidrofuryl or inositol nicotinate may also be prescribed by some doctors to treat Raynaud's phenomenon.
Continuez à lire ci-dessous
How should peripheral vasodilators be taken?
Retour au sommaireHow nifédipine is taken will depend upon the pattern of symptoms and how well symptoms improve with treatment.
All other vasodilators are taken every day.
Quels sont les effets secondaires possibles ?
Retour au sommaireMost people who take peripheral vasodilators have no side-effects, or only minor ones. It is not possible in this leaflet to list all the possible side-effects of these medicines. For more detailed information, see the leaflet that comes within the medicine packet.
Nifédipine - some people develop flushing and des maux de tête. Serious side-effects are rare.
Naftidrofuryl - the most commonly reported side-effects are feeling sick, skin rash, stomach pains and runny stools (diarrhée). On rare occasions, some people taking naftidrofuryl have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.
Cilostazol - the most common side-effects include headache and diarrhoea. Less common side-effects include vertiges, weakness, feeling or being sick, l'indigestion, tummy (abdominal) pain, fast heartbeat, chest pain, runny nose, bruising, swollen ankles or feet, skin rash and itching.
Inositol nicotinate - side-effects are thought to be uncommon but may include flushing, dizziness, headache, feeling sick, being sick (vomiting), fainting and a rash.
Moxisylyte - the most common side-effects include mild nausée, diarrhoea, dizziness with a spinning sensation (vertige), headache, facial flushing and a rash. On rare occasions, some people taking moxisylyte have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.
Pentoxifylline - the most common side-effects include nausea, vomiting, and dizziness which may occur. Uncommonly, some people experience a fast or irregular heartbeat.
Other considerations - nifedipine
Retour au sommaireDrinking grapefruit juice can interact with nifedipine and alter its effect. Therefore, grapefruit juice should be avoided by anyone taking this particular vasodilator.
Can I buy peripheral vasodilators?
Retour au sommaireNo, you cannot buy oral peripheral vasodilators; you need a prescription to obtain these medicines.
Who cannot take peripheral vasodilators?
Retour au sommaireMost people are able to take a peripheral vasodilator; however, in some cases these medicines are best avoided.
Nifédipine - should not be given to people who:
Have severe damage to the heart muscle (cardiogenic shock).
Have a valve in the heart that does not open fully (advanced aortic stenosis).
Are within one month of having had a crise cardiaque.
Have acute attacks of angine de poitrine.
Naftidrofuryl - should not be given to people with a history of calculs rénaux.
Cilostazol - should not be given to people with:
Severe kidney or liver problems.
Uncontrolled l'hypertension artérielle.
Des ulcère de l'estomac.
A history of having had surgery in the previous three months.
A history of having had a AVC in the previous six months.
Inositol nicotinate - should not be given to people who have had a recent heart attack (myocardial infarction) or stroke.
Moxisylyte - is safe to use in most people.
Pentoxifylline - should not be given to people who have had:
A stroke.
Extensive back of the eye (retinal) bleeding.
A heart attack.
Heart rhythm problems.
For more detailed information, see the leaflet that comes with the medicine packet.
Patient picks for Médicaments pour le cœur et le sang

Traitement et médicaments
Bloqueurs des canaux calciques
Les bloqueurs des canaux calciques (parfois appelés antagonistes calciques) sont un groupe de médicaments qui influencent la façon dont le calcium pénètre dans certaines cellules musculaires. Ils sont couramment prescrits pour gérer l'hypertension, l'angine de poitrine, le phénomène de Raynaud et certains troubles du rythme cardiaque (arythmies). Ils sont également utilisés pour tenter d'arrêter le travail prématuré pendant la grossesse. Un bloqueur des canaux calciques peut être utilisé seul. Cependant, il est souvent associé à un autre médicament pour traiter l'hypertension ou l'angine, lorsque qu'un seul médicament n'a pas été suffisamment efficace.
par Dr Toni Hazell, MRCGP

Traitement et médicaments
Inhibiteurs de l'ECA
ACE inhibitors are medicines that are used mainly in the treatment of high blood pressure (hypertension) and heart failure. They are also used in some people with diabetes, for some forms of kidney disease, and after a heart attack, to help protect the heart. They have a variety of effects on the body. Their ability to relax blood vessels is one of the most important. The side-effects most commonly associated with ACE inhibitors are usually minor. A common side-effect is a persistent dry cough.
par Dr Toni Hazell, MRCGP

Vous n'êtes pas sûr de mélanger des médicaments ?
Vérifiez les interactions possibles entre les médicaments, les compléments et les aliments avant de les prendre ensemble.
Questions fréquemment posées
Can I take peripheral vasodilators if I'm already taking other medications?
The article mentions that grapefruit juice can interact with nifedipine and alter its effect, so it should be avoided. For information regarding other potential interactions with other medications, you would need to refer to the detailed leaflet that comes with your medicine packet, as this article does not cover all possible interactions.
What should I do if I notice yellowing of my skin or eyes while taking naftidrofuryl or moxisylyte?
On rare occasions, some people taking naftidrofuryl or moxisylyte have developed a liver disorder. If you notice any yellowing of your skin or the whites of your eyes, you should speak with a doctor straightaway.
Are there any alternative treatments for Raynaud's phenomenon if nifedipine isn't suitable for me?
If nifedipine's side-effects cannot be tolerated, a doctor may consider prescribing a different calcium-channel blocker, such as nicardipine, amlodipine, or felodipine. Additionally, in rare cases, naftidrofuryl or inositol nicotinate may also be prescribed by some doctors to treat Raynaud's phenomenon.
How long does it take for peripheral vasodilators to show an improvement in symptoms?
For intermittent claudication, if an improvement in symptoms is not seen within a few weeks, continuing with the medicine is not recommended and stopping treatment would usually be advised. If symptoms improve, treatment can be continued.
Why are some peripheral vasodilators considered ineffective for certain conditions?
For peripheral arterial disease, inositol nicotinate and pentoxifylline are not considered effective. For Raynaud's phenomenon, pentoxifylline and moxisylyte are not considered effective. This is because there is little evidence that these specific drugs work very well for those particular conditions, as stated in the national guidelines and medical evidence.
If I experience a side-effect, what is the 'Yellow Card Scheme' and how do I use it?
The Yellow Card Scheme is a system where you can report any suspected side-effects you experience from medicines or other healthcare products. You can do this online at www.mhra.gov.uk/yellowcard. When reporting, it's helpful to have information about the side-effect, the name of the medicine, details of the person who had the side-effect, and your contact information.
Lectures complémentaires et références
- Lower limb peripheral arterial disease; NICE Clinical Guideline (August 2012, updated December 2020)
- Aboyans V, Ricco JB, Bartelink MEL, et al; 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017 Aug 26. doi: 10.1093/eurheartj/ehx095.
- Su KY, Sharma M, Kim HJ, et al; Vasodilators for primary Raynaud's phenomenon. Cochrane Database Syst Rev. 2021 May 17;5:CD006687. doi: 10.1002/14651858.CD006687.pub4.
- Phénomène de Raynaud; NICE CKS, novembre 2022 (accès réservé au Royaume-Uni)
- Peripheral Arterial Disease; NICE CKS, mars 2024 (accès réservé au Royaume-Uni)
- Golledge J, Drovandi A; Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb. 2021 Jun 1;28(6):573-583. doi: 10.5551/jat.62778. Epub 2021 Mar 21.
Continuez à lire ci-dessous
About the authorView full bio

Dr Surangi Mendis, MRCGP
Consultant and Medical Author
MBBS, BSc (1st), MRCGP (2014), DFSRH, PGcert otology and audiology
Surangi Mendis is a consultant in Audiovestibular Medicine and Neuro-otology at The Royal National ENT and Eastman Dental Hospitals, UCLH.
About the reviewerView full bio

Dr Philippa Vincent, MRCGP
Médecin généraliste, Auteur médical
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dr Philippa Vincent is an NHS GP working in North London.
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Prochaine révision prévue : 26 sept. 2028
28 sept. 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
By subscribing you accept our Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.